MEDIZINISCHER KAUGUMMI

European patent · EP3129011 · In force

Register entry

Publication number
EP3129011
Application number
EP15716421
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Apr 8, 2015
Published
Feb 15, 2017
Granted
Jun 7, 2023
Protection ends at the latest
Apr 7, 2035
Next annual fee due
Apr 30, 2027
IPC classes
A61K 9/68 (2006.01)
A61K 47/32 (2006.01)
A61K 31/465 (2006.01)
A24B 13/00 (2006.01)
A23G 4/06 (2006.01)
A23G 4/08 (2006.01)
A23G 4/12 (2006.01)
A61P 25/26 (2006.01)
Priority
DK 201470183 08.04.2014
PCT application
PCT/DK2015/050084 08.04.2015
PCT publication
WO2015/154780 15.10.2015
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 1, 2026

    Change

    Published in Swissreg on 01.05.2026

  2. May 1, 2025

    Change

    Published in Swissreg on 01.05.2025

  3. May 1, 2024

    Change

    Published in Swissreg on 01.05.2024

  4. Apr 24, 2024

    Change

    Published in Swissreg on 24.04.2024

  5. Apr 17, 2024

    Change

    Published in Swissreg on 17.04.2024

  6. Jun 15, 2023

    Agent entered

    Representative
    Novagraaf International SA, Chemin de l'Echo 3, 1213 Onex

    Published in Swissreg on 15.06.2023

  7. Jun 7, 2023

    Granted

    Published in Swissreg on 07.06.2023

Parties

Holder

Fertin Pharma A/S

Dandyvej 19, 7100 Vejle, DK

Agent

Novagraaf International SA

Chemin de l'Echo 3, 1213 Onex

Inventor

NEERGAARD, Jesper

DK-6200 Aabenraa, DK

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.